Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine added to Del-Nido cardioplegic solution for myocardial protection in pediatric cardiac surgery
IRCT20240415061492N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexmedetomidine in Cardiovascular Malformation (CVM), sponsored by Mashhad University of Medical Sciences. Started May 2024; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on IRCT20240415061492N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240415061492N1.